Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the USShruti Gupta, Jean-Sébastien Rachoin, Samuel Short et al.|JAMA Internal Medicine|2020Cited by 1k
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19Shruti Gupta, Sushrut S. Waikar, Shahzad Shaefi et al.|JAMA Internal Medicine|2020Cited by 555
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United StatesJennifer E. Flythe, Samantha K. Brenner, Shahzad Shaefi et al.|American Journal of Kidney Diseases|2020Cited by 234
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19Hanny Al‐Samkari, Shahzad Shaefi, Roberta E. Redfern et al.|Annals of Internal Medicine|2021Cited by 140
Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19Charles R. Vasquez, Steven G. Coca, Shahzad Shaefi et al.|CHEST Journal|2021Cited by 40